UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009044
Receipt number R000010620
Scientific Title Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoring
Date of disclosure of the study information 2012/10/05
Last modified on 2013/04/02 16:36:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoring

Acronym

Anesthesia with dexmedetomidine and effects on spinal cord monitoring

Scientific Title

Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoring

Scientific Title:Acronym

Anesthesia with dexmedetomidine and effects on spinal cord monitoring

Region

Japan


Condition

Condition

Spinal cord tumors, spinal disorders

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy and safety of dexmedetomidine as a general anesthetic. Spinal cord monitoring is monitoring of the spinal cord function to avoid nerve damage by surgical manipulations of the spine and spinal cord. The effects of dexmedetomidine on spinal cord monitoring are evaluated.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

To evaluate the depth of anesthesia by BIS monitoring to validate the hypothesis that dexmedetomidine is effective as a general anesthetic.

Key secondary outcomes

To measure the amplitude and latency of the waveform obtained by spinal cord monitoring under general anesthesia using dexmedetomidine, and to evaluate its clinical advantages and safety.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

The degree of sedation is evaluated on the basis of the value of the bispectral index calculated by BIS monitoring of brain waves, and the dose of dexmedetomidine is adjusted during surgery while monitoring the degree of surgical stress and hemodynamics. Dexmedetomidine is administered by continuous intravenous infusion. The amplitude and latency of the waveforms obtained by spinal cord monitoring are measured under general anesthesia with dexmedetomidine. Blood (1 ml) is sampled every hour to measure the blood dexmedetomidine concentration. The measurements are performed during the period of anesthetic management.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who are scheduled to undergo surgery of the spine or spinal cord at a Niigata university Medical and Dental hospital and need intraoperative spinal cord monitoring, those who are scheduled to be admitted to the ICU after surgery, those with histories of egg and soy bean allergy or convulsive attacks, those in whom the use of ketamine is difficult, those with GABA (A) receptor deletion, and those who consented to participation in the study after a sufficient explanation.

Key exclusion criteria

1. Patients who are or may be pregnant.
2. Patients undergoing blood purification therapy.
3. Patients with cardiovascular disorders.
4. Patients with reduced cardiac function.
5. Patients with a reduced circulating blood volume.
6. Patients with liver dysfunction.
7. Patients with kidney dysfunction.
8. Old patients (75 years or above).
9. Patients judged to be inappropriate.

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideaki Ishii

Organization

Niigata University

Division name

Medical and Dental Hospital, Anesthesiology

Zip code


Address

1-757 Asahi-machi, Chuo-ku, Niigata

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Hideaki Ishii

Organization

Niigata University

Division name

Medical and Dental Hospital, Anesthesiology

Zip code


Address

1-757 Asahi-machi, Chuo-ku, Niigata

TEL


Homepage URL


Email



Sponsor or person

Institute

Niigata University Medical and Dental Hospital, Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

Niigata University Medical and Dental Hospital

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

新潟大学医歯学総合病院(新潟県)


Other administrative information

Date of disclosure of the study information

2012 Year 10 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 26 Day

Date of IRB


Anticipated trial start date

2011 Year 01 Month 26 Day

Last follow-up date

2013 Year 04 Month 01 Day

Date of closure to data entry

2013 Year 04 Month 02 Day

Date trial data considered complete

2013 Year 04 Month 02 Day

Date analysis concluded

2013 Year 04 Month 02 Day


Other

Other related information



Management information

Registered date

2012 Year 10 Month 05 Day

Last modified on

2013 Year 04 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010620


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name